Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 290(48): 28944-52, 2015 Nov 27.
Article in English | MEDLINE | ID: mdl-26254469

ABSTRACT

Transmembrane topology of polytopic membrane proteins (PMPs) is established in the endoplasmic reticulum (ER) by the ribosome Sec61-translocon complex (RTC) through iterative cycles of translocation initiation and termination. It remains unknown, however, whether tertiary folding of transmembrane domains begins after the nascent polypeptide integrates into the lipid bilayer or within a proteinaceous environment proximal to translocon components. To address this question, we used cysteine scanning mutagenesis to monitor aqueous accessibility of stalled translation intermediates to determine when, during biogenesis, hydrophilic peptide loops of the aquaporin-4 (AQP4) water channel are delivered to cytosolic and lumenal compartments. Results showed that following ribosome docking on the ER membrane, the nascent polypeptide was shielded from the cytosol as it emerged from the ribosome exit tunnel. Extracellular loops followed a well defined path through the ribosome, the ribosome translocon junction, the Sec61-translocon pore, and into the ER lumen coincident with chain elongation. In contrast, intracellular loops (ICLs) and C-terminalresidues exited the ribosome into a cytosolically shielded environment and remained inaccessible to both cytosolic and lumenal compartments until translation was terminated. Shielding of ICL1 and ICL2, but not the C terminus, became resistant to maneuvers that disrupt electrostatic ribosome interactions. Thus, the early folding landscape of polytopic proteins is shaped by a spatially restricted environment localized within the assembled ribosome translocon complex.


Subject(s)
Aquaporin 4/metabolism , Endoplasmic Reticulum/metabolism , Intracellular Membranes/metabolism , Membrane Proteins/metabolism , Protein Folding , Ribosomes/metabolism , Aquaporin 4/chemistry , Aquaporin 4/genetics , Endoplasmic Reticulum/chemistry , Endoplasmic Reticulum/genetics , Humans , Intracellular Membranes/chemistry , Membrane Proteins/chemistry , Membrane Proteins/genetics , Protein Structure, Secondary , Ribosomes/chemistry , Ribosomes/genetics , SEC Translocation Channels
2.
Science ; 348(6233): 444-8, 2015 Apr 24.
Article in English | MEDLINE | ID: mdl-25908822

ABSTRACT

In cells, biosynthetic machinery coordinates protein synthesis and folding to optimize efficiency and minimize off-pathway outcomes. However, it has been difficult to delineate experimentally the mechanisms responsible. Using fluorescence resonance energy transfer, we studied cotranslational folding of the first nucleotide-binding domain from the cystic fibrosis transmembrane conductance regulator. During synthesis, folding occurred discretely via sequential compaction of N-terminal, α-helical, and α/ß-core subdomains. Moreover, the timing of these events was critical; premature α-subdomain folding prevented subsequent core formation. This process was facilitated by modulating intrinsic folding propensity in three distinct ways: delaying α-subdomain compaction, facilitating ß-strand intercalation, and optimizing translation kinetics via codon usage. Thus, de novo folding is translationally tuned by an integrated cellular response that shapes the cotranslational folding landscape at critical stages of synthesis.


Subject(s)
Codon/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator/biosynthesis , Cystic Fibrosis Transmembrane Conductance Regulator/chemistry , Peptide Chain Elongation, Translational , Protein Folding , Amino Acid Sequence , Codon/chemistry , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Fluorescence Resonance Energy Transfer , Humans , Kinetics , Molecular Sequence Data , Protein Structure, Secondary , Protein Structure, Tertiary , Ribosomes/chemistry , Ribosomes/metabolism
3.
Methods Mol Biol ; 741: 233-53, 2011.
Article in English | MEDLINE | ID: mdl-21594789

ABSTRACT

Cell-free expression systems provide unique tools for understanding CFTR biogenesis because they reconstitute the cellular folding environment and are readily amenable to biochemical and pharmacological manipulation. The most common system for this purpose is rabbit reticulocyte lysate (RRL), supplemented with either canine pancreatic microsomes or semi-permeabilized cells, which has yielded important insights into the folding of CFTR and its individual domains. A common problem in such studies, however, is that biogenesis of large proteins such as CFTR is often inefficient due to low translation processivity, ribosome stalling, and/or premature termination. The first part of this chapter therefore describes parameters that affect in vitro translation of CFTR in RRL. We have found that CFTR expression is uniquely dependent upon 5'- and 3'-untranslated regions (UTRs) of the mRNA. Full-length CFTR expression can be markedly increased using mRNA lacking a 5'-cap analog (G(5')ppp(5')G), whereas the reverse usually holds for smaller proteins and individual CFTR domains. In the context of the full-length mRNA, translation was further stimulated by the presence of a long 3'-UTR. The second part of this chapter describes CFTR translation in lysates derived from cultured mammalian cells including human bronchial epithelial cells. Unfortunately, mammalian cell-derived lysates showed limited ability to sustain full-length CFTR synthesis. However, they provide a unique opportunity to examine specific CFTR domains (i.e., nucleotide-binding domain 1 and transmembrane domain 1) under conditions that more closely resemble the native folding environment.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/biosynthesis , Reticulocytes/cytology , 3' Untranslated Regions/genetics , Animals , Cell Extracts , Cell Line , Cell-Free System/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Dogs , Endoplasmic Reticulum/metabolism , Eukaryotic Initiation Factor-2/genetics , Gene Expression , Humans , Intracellular Membranes/metabolism , Mice , Microsomes/metabolism , Mutation , Protein Biosynthesis , RNA Caps/genetics , Rabbits , Reticulocytes/metabolism , Transcription, Genetic
4.
Biophys J ; 83(6): 3304-14, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12496098

ABSTRACT

Functional N-methyl-D-aspartate receptors (NMDARs) are heteromultimers formed by NR1 and NR2 subunits. The M3 segment, as contributed by NR1, forms the core of the extracellular vestibule, including binding sites for channel blockers, and represents a critical molecular link between ligand binding and channel opening. Taking advantage of the substituted cysteine accessibility method along with channel block and multivalent coordination, we studied the contribution of the M3 segment in NR2C to the extracellular vestibule. We find that the M3 segment in NR2C, like that in NR1, contributes to the core of the extracellular vestibule. However, the M3 segments from the two subunits are staggered relative to each other in the vertical axis of the channel. Compared to NR1, homologous positions in NR2C, including those in the highly conserved SYTANLAAF motif, are located about four amino acids more externally. The staggering of subunits may represent a key structural feature underlying the distinct functional properties of NMDARs.


Subject(s)
Protein Subunits/physiology , Receptors, N-Methyl-D-Aspartate/physiology , Aminacrine/pharmacology , Amino Acid Sequence , Animals , Cations/pharmacology , Cell Membrane/drug effects , Cell Membrane/physiology , Cells, Cultured , Cysteine/chemistry , Cysteine/genetics , Extracellular Space/chemistry , Extracellular Space/physiology , Female , Glutamic Acid/pharmacology , Ion Channel Gating/drug effects , Ion Channel Gating/physiology , Ion Channels/drug effects , Ion Channels/physiology , Macromolecular Substances , Membrane Potentials/drug effects , Membrane Potentials/physiology , Mesylates/pharmacology , Molecular Sequence Data , Mutagenesis, Site-Directed , Oocytes/chemistry , Oocytes/drug effects , Oocytes/physiology , Protein Conformation , Protein Subunits/chemistry , Receptors, N-Methyl-D-Aspartate/chemistry , Sequence Homology, Amino Acid , Silver/pharmacology , Xenopus/physiology
5.
Am J Physiol Lung Cell Mol Physiol ; 282(2): L197-206, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11792624

ABSTRACT

We reported previously that mast cell tryptase is a growth factor for dog tracheal smooth muscle cells. The goals of our current experiments were to determine if tryptase also is mitogenic in cultured human airway smooth muscle cells, to compare its strength as a growth factor with that of other mitogenic serine proteases, and to determine whether its proteolytic actions are required for mitogenesis. Highly purified preparations of human lung beta-tryptase (1-30 nM) caused dose-dependent increases in DNA synthesis in human airway smooth muscle cells. Maximum tryptase-induced increases in DNA synthesis far exceeded those occurring in response to coagulation cascade proteases, such as thrombin, factor Xa, or factor XII, or to other mast cell proteases, such as chymase or mastin. Irreversibly abolishing tryptase's catalytic activity did not alter its effects on increases in DNA synthesis. We conclude that beta-tryptase is a potent mitogenic serine protease in cultured human airway smooth muscle cells. However, its growth stimulatory effects in these cells occur predominantly via nonproteolytic actions.


Subject(s)
Mitogens/metabolism , Muscle, Smooth/enzymology , Serine Endopeptidases/metabolism , Trachea/enzymology , Animals , Anticoagulants/pharmacology , Becaplermin , Cell Division/drug effects , Cell Division/physiology , Cells, Cultured , Chymases , DNA/biosynthesis , Dogs , Dose-Response Relationship, Drug , Epidermal Growth Factor/pharmacology , Factor XII/pharmacology , Factor Xa/pharmacology , Fibroblast Growth Factor 2/pharmacology , Hemostatics/pharmacology , Humans , Hyperplasia , Insulin-Like Growth Factor I/pharmacology , Mast Cells/enzymology , Mast Cells/immunology , Mitogens/pharmacology , Muscle, Smooth/cytology , Muscle, Smooth/immunology , Platelet-Derived Growth Factor/pharmacology , Proto-Oncogene Proteins c-sis , RNA, Messenger/analysis , Receptor, PAR-2 , Receptors, Thrombin/genetics , Serine Endopeptidases/pharmacology , Thrombin/pharmacology , Trachea/cytology , Trachea/immunology , Tryptases
SELECTION OF CITATIONS
SEARCH DETAIL
...